Ultrasound criteria of uterine scar secondary to placenta accreta spectrum metroplasty and use of platelet-rich plasma
- Authors: Mikheeva A.A.1, Yarygina T.A.2, Shmakov R.G.1, Kostyukov K.V.1, Rogachevsky O.V.1, Pyregov A.V.1
-
Affiliations:
- Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
- A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Ministry of Health of the Russian Federation
- Issue: No 3 (2023)
- Pages: 41-50
- Section: Original Articles
- URL: https://journals.rcsi.science/0300-9092/article/view/258610
- DOI: https://doi.org/10.18565/aig.2023.19
- ID: 258610
Cite item
Abstract
Objective: To evaluate the effects of platelet-rich plasma (PRP) injections on uterine scar formation following metroplasty in patients with placenta accreta spectrum.
Materials and methods: This blinded randomized controlled trial included 100 women who underwent surgery for placenta accreta spectrum between November 2020 and July 2022. Patients who met the inclusion criteria were randomly assigned to receive intramyometrial PRP injections (interventional group, n=48) or not (control group, n=52). Patients in both groups were examined at 12 weeks postoperatively. Clinical evaluation included ultrasound examination according to the Delphi protocol, analysis of clinical data, and assessment of medical history and quality of life.
Results: Comparison of the scar characteristics showed a significantly lower incidence of niche formation in the intervention group (31.2 %) compared to control group (65.4 %) (p<0.001). The mean residual myometrium thickness (RMT) in the study and control groups was 7.2 (2.95) and 4.3 (3.5) mm, respectively (p<0.001). The largest niche widths were 7 and 11 mm (p<0.001), the largest depths were 6 and 8 mm (p=0.018), and the largest lengths were 11 and 13 mm. (p=0.101) mm in the study and control groups, respectively. The thickness of the adjacent myometrium was comparable between groups (p=0.143).
Conclusion: This pilot randomized trial showed that intraoperative intramyometrial PRP injection is an effective technique for improving myometrial tissue regeneration and enhancing the quality of uterine scars in the metroplasty area. Therefore, this technology can be proposed for use in the routine practice of operative obstetrics, including for metroplasty after placenta accreta spectrum.
Full Text
##article.viewOnOriginalSite##About the authors
Alexandra A. Mikheeva
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Author for correspondence.
Email: shuratora@mail.ru
ORCID iD: 0000-0002-8159-6373
Postgraduate Student
Russian Federation, MoscowTamara A. Yarygina
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Ministry of Health of the Russian Federation
Email: tamarayarygina@gmail.com
ORCID iD: 0000-0001-6140-1930
PhD, Diagnostic Medical Sonographer, Perinatal Cardiology Center
Russian Federation, MoscowRoman G. Shmakov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: r_shmakov@oparina4.ru
ORCID iD: 0000-0002-2206-1002
Dr. Med. Sci., Professor, Director of the Institute of Obstetrics
Russian Federation, MoscowKirill V. Kostyukov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: kostyukov_k@yahoo.com
ORCID iD: 0000-0003-3094-4013
Dr. Med. Sci., Head of the Ultrasound Department
Russian Federation, MoscowOleg V. Rogachevsky
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: o_rogachevskiy@oparina4.ru
ORCID iD: 0000-0002-4332-430X
Dr. Med. Sci., Head of the Department of Extracorporal Methods of Treatment and Detoxification, Professor at the Department of Anesthesiology and Resuscitation
Russian Federation, MoscowAleksey V. Pyregov
Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation
Email: pyregov@oparina4.ru
ORCID iD: 0000-0001-8382-9671
Dr. Med. Sci., Director of the Institute of Anesthesiology and Intensive Care
Russian Federation, MoscowReferences
- Soto-Vega E., Casco S., Chamizo K., Flores-Hernÿndez D., Landini V., Guillén-Florez A. Rising trends of cesarean section worldwide: a systematic review. Obstet. Gynecol. Int. J. 2015; 3(2): 00073. https://dx.doi.org/10.15406/ogij.2015.03.00073
- Stegwee S.I., Jordans I.P.M., van der Voet L.F., Bongers M.Y., de Groot C.J.M., Lambalk C.B. et al. Single-versus double-layer closure of the caesarean (uterine) scar in the prevention of gynaecological symptoms in relation to niche development–the 2Close study: a multicentre randomised controlled trial. BMC Pregnancy Childbirth. 2019; 19(1): 85. https://dx.doi.org/10.1186/s12884-019-2221-y
- Litwicka K., Greco E. Caesarean scar pregnancy: a review of management options. Curr. Opin. Obstet. Gynecol. 2013; 25(6): 456-61. https://dx.doi.org/10.1097/GCO.0000000000000023
- Bij de Vaate A.J., van der Voet L.F., Naji O., Witmer M., Veersema S., Brolmann H.A. et al. Prevalence, potential risk factors for development and symptoms related to the presence of uterine niches following Cesarean section: systematic review. Ultrasound Obstet. Gynecol. 2014; 43(4): 372-82. https://dx.doi.org/10.1002/uog.13199
- Hou R., Liu C., Li N., Yang T. Obstetric complications and outcomes of singleton pregnancy with previous caesarean section according to maternal age. Placenta. 2022; 128: 62-8. https://dx.doi.org/10.1016/j.placenta.2022.08.060
- Supermainam S., Koh E.T. Laparoscopic partial bladder cystectomy for bladder endometriosis: a combined cystoscopic and laparoscopic approach. J. Minim. Invasive Gynecol. 2020; 27(3): 575-6. https://dx.doi.org/10.1016/ j.jmig.2019.06.020
- Tower A.M., Frishman G.N. Cesarean scar defects: an underrecognized cause of abnormal uterine bleeding and other gynecologic complications. J. Minim. Invasive Gynecol. 2013; 20(5): 562-72. https://dx.doi.org/10.1016/ j.jmig.2013.03.008
- Jordans I.P.M., De Leeuw R.A., Stegwee S.I., Amso N.N., Barri‐Soldevila P.N., van den Bosch T. et al. Sonographic examination of uterine niche in non‐pregnant women: a modified Delphi procedure. Ultrasound Obstet. Gynecol. 2019; 53(1): 107-15. https://dx.doi.org/10.1002/uog.19049
- Flood K.M., Said S., Geary M., Robson M., Fitzpatrick C., Malone F.D. Changing trends in peripartum hysterectomy over the last 4 decades. Am. J. Obstet. Gynecol. 2009; 200(6): 632. e1-632. e6. https://dx.doi.org/10.1016/ j.ajog.2009.02.001
- Morlando M., Sarno L., Napolitano R., Capone A., Tessitore G., Maruotti G.M. et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet. Gynecol. Scand. 2013; 92(4): 457-60. https://dx.doi.org/10.1111/aogs.12080
- Dawood A.S., Salem H.A. Current clinical applications of platelet-rich plasma in various gynecological disorders: An appraisal of theory and practice. Clin. Exp. Reprod. Med. 2018; 45(2): 67-74. https://dx.doi.org/10.5653/cerm.2018.45.2.67
- Tehranian A., Esfehani-Mehr B., Pirjani R., Rezaei N., Sadat Heidary S., Sepidarkish M. Application of autologous platelet-rich plasma (PRP) on wound healing after Caesarean section in high-risk patients. Iran. Red Crescent Med. J. 2016; 18(7): e34449. https://dx.doi.org/10.5812/ircmj.34449
- Аполихина И.А., Эфендиева З.Н., Федорова Т.А., Белоусов Д.М., Вишнякова П.А., Артемова Д.А., Фатхудинов Т.Х. Обогащенная тромбоцитами аутологичная плазма в комплексной терапии женщин с рефрактерным «тонким» эндометрием. Акушерство и гинекология. 2021; 4: 112-9. [Apolikhina I.A., Efendieva Z.N., Fedorova T.A., Belousov D.M., Vishnyakova P.A., Artemova D.A., Fatkhudinov T.Kh. Platelet-rich autologous plasma in the complex therapy of women with refractory "thin" endometrium. Obstetrics and Gynecology. 2021; (4): 112-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.4.112-119
- Hamar B.D., Saber S.B., Cackovic M., Magloire L.K., Pettker C.M., Abdel-Razeq S.S. et al. Ultrasound evaluation of the uterine scar after cesarean delivery: A randomized controlled trial of one- and two-layer closure. Obstet. Gynecol. 2007; 110(4): 808-13. https://dx.doi.org/10.1097/ 01.AOG.0000284628.29796.80
- Hall M.P., Band P.A., Meislin R.J., Jazrawi L.M., Cardone D.A. Platelet-rich plasma: current concepts and application in sports medicine. J. Am. Acad. Orthop. Surg. 2009; 17(10): 602-8. https://dx.doi.org/10.5435/ 00124635-200910000-00002
- Гус А.И., Ярыгина Т.А., Михеева А.А., Воеводина В.И., Шмаков Р.Г. Стандартизированное исследование послеоперационного рубца на матке. Акушерство и гинекология. 2022; 1: 42-7. [Gus A.I., Yarygina T.A., Mikheeva A.A., Voevodina V.I., Shmakov R.G. Standardized study of postoperative scar on the uterus. Obstetrics and Gynecology. 2022; (1): 42-7. (in Russian)]. https://dx.doi.org/10.18565/aig.2022.1.42-47
- Кабатин Н.А., Калинин В.В., Щерина А.В., Полонецкий А.Я., Смирнов А.В. Синдром Огилви как редкое хирургическое осложнение после операции кесарева сечения. Акушерство и гинекология. 2021; 5: 199-203. [Kabatin N.A., Kalinin V.V., Shcherina A.V., Polonetsky A.Ya., Smirnov A.V. Ogilvie's syndrome as a rare surgical complication after caesarean section. Obstetrics and Gynecology. 2021; (5): 199-203. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.5.199-203
- Fiocchi F., Petrella E., Nocetti L., Curra S., Ligabue G., Costi T. et al. Transvaginal ultrasound assessment of uterine scar after previous caesarean section: comparison with 3T-magnetic resonance diffusion tensor imaging. Radiol. Med. 2015; 120(2): 228-38. https://dx.doi.org/10.1007/ s11547-014-0431-y
- van der Voet L.L.F., Limperg T., Veersema S., Timmermans A., Bij de Vaate A.M.J., Brolmann H.A.M., Huirne J.A.F. Niches after cesarean section in a population seeking hysteroscopic sterilization. Eur. J. Obstet. Gynecol. Reprod. Biol. 2017; 214: 104-8. https://dx.doi.org/10.1016/j.ejogrb.2017.05.004
- Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Tromb. Haemost. 2014; 91: 4-15. https://dx.doi.org/10.1160/TH03-07-0440
- Chaichian S., MirgaloybayatS., Tahermanesh1 K., Hossein Mohammadi M., Mostafavi R.S., Mehdizadehkashi A. et al. Effect of autologous platelet–rich plasma on cesarean section scar; a randomized, double-blinded pilot study. Shiraz E-Med. J. 2022; 23(1): e114072. https://dx.doi.org/10.5812/semj.114072
- Marx R. What determines the therapeutic effectiveness of the injectable form of PRP? Cortexil PRP. 2022; 22: 12-8
- Gentile P., Garcovich S. Systematic review – the potential implications of different platelet-rich plasma (Prp) concentrations in regenerative medicine for tissue repair. Int. J. Mol. Sci. 2020; 21(16): 5702. https://dx.doi.org/10.3390/ijms21165702